ABBV vs STE
By Alex · Tickerpine
AbbVie Inc. vs STERIS plc, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | STE |
|---|---|---|
| Price | $264.34 | $208.93 |
| Market cap | $467.12B | $20.37B |
| P/E ratio | 74.5 | 25.5 |
| ROE | — | 11.39% |
| Profit margin | 9.80% | 13.33% |
| Revenue growth | 10.20% | 7.30% |
| Dividend yield | 2.62% | 1.23% |
| Beta | 0.28 | 0.91 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs STE in plain English
- ABBV is the bigger company — about 22.9× the market cap of STE.
- STE is cheaper on earnings (P/E 25.5 vs 74.5).
- ABBV is growing revenue faster (10% vs 7%).
- ABBV has the higher dividend yield (2.62% vs 1.23%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
STE return calculator
See what $1,000 in STERIS plc would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.